Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)

Clinical trial NCT02354534 · COMPLETED

Trial details

NCT number: NCT02354534
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia Grade 2/3 High-risk HPV (Any Strain)

Start date: 2015-02-01
Primary completion: 2018-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.